DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Arthur Klausner to be a panelist at the 12th Annual Drug Delivery Partnerships Conference in San Diego, CA
News | 01. 21. 2008
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.